Progenics Pharmaceuticals, Inc. (PGNX)

Oncology Corporate Profile

Stock Performance

5.4600
0.0800

HQ Location

777 Old Saw Mill River Road
Tarrytown, NY 10591

Company Description

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics' first-in-class PSMA targeted technology platform for prostate cancer includes an antibody drug conjugate therapeutic in a two-cohort phase 2 clinical trial and a small molecule imaging agent that has completed patient dosing in a phase 2 trial. Among other assets in its pipeline of targeted radiotherapy and molecular imaging compounds is Azedra™, an ultra-orphan radiotherapy candidate also in a phase 2 study under an SPA. Progenics' first commercial product, RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for opioid-induced constipation, is partnered with and marketed by Salix Pharmaceuticals, Inc.

Website: http://www.progenics.com

Brand Generic Indication
Relistor®methylnaltrexone bromideRelistor® (methylnaltrexone bromide) is indicated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient. Use of Relistor® beyond four months has not been studied.
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
1404Tc-99m diagnostic imaging agentProstate cancerIII
PyLF-18 diagnostic imaging agentProstate cancerII
1095I-131 small molecule theranosticProstate cancerII
Azedra®I-131 theranostic (MIBG)ParagangliomaII
Azedra®I-131 theranostic (MIBG)Pheochromocytoma¾II
1404PSMA Targeting imaging agentProstate cancerPreclinical

Source: http://www.progenics.com

Recent News Headlines

5/27/2017 06:18 am

5/27/2017 06:18 am

5/27/2017 06:18 am

5/27/2017 06:18 am

5/27/2017 06:18 am

5/18/2017 12:18 pm

5/18/2017 12:18 pm

5/18/2017 12:18 pm

5/18/2017 12:18 pm

5/18/2017 12:18 pm

5/12/2017 06:18 am

5/12/2017 06:18 am

5/9/2017 12:18 pm

5/9/2017 12:18 pm

5/9/2017 12:18 pm

5/9/2017 12:18 pm

5/9/2017 12:18 pm

5/9/2017 06:18 am

5/8/2017 06:19 am

5/5/2017 06:18 am

5/5/2017 06:18 am

5/5/2017 06:18 am

5/5/2017 06:18 am

5/5/2017 06:18 am

5/4/2017 06:18 pm